• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人脑中代谢酶和谷氨酸脱羧酶的区域活性

Regional activities of metabolic enzymes and glutamate decarboxylase in human brain.

作者信息

Maker H S, Weiss C, Weissbarth S, Silides D J, Whetsell W

出版信息

Ann Neurol. 1981 Oct;10(4):377-83. doi: 10.1002/ana.410100410.

DOI:10.1002/ana.410100410
PMID:7316490
Abstract

Interpretation of biochemical measurements in the human brain after death is complicated by a variety of premortem, perimortem, and postmortem factors. The activity of glutamic acid decarboxylase (GAD) in particular has been found to vary considerably among human brains. In contrast to neurotransmitter-associated enzymes, metabolic enzymes are present in all brain cells and should not be specifically lost by patterned neuronal cell loss such as that which occurs in Parkinson disease. We compared the activity of GAD to that of the metabolic enzymes creatine kinase (CK), adenylate kinase, hexokinase, beta-glucuronidase, and malate, lactate, glucose-6-phosphate, and isocitrate dehydrogenases in 24 regions of six human brains. Of the metabolic enzymes, only CK showed a 5-fold variation approaching that of GAD. Like GAD, CK activity was stable postmortem, but its activity was apparently inversely related to the severity and duration of the preterminal illness. CK may be a useful marker of agonal deterioration.

摘要

死后对人类大脑进行生化测量的解读会受到各种生前、濒死期和死后因素的影响。特别是,已发现谷氨酸脱羧酶(GAD)的活性在人类大脑中差异很大。与神经递质相关酶不同,代谢酶存在于所有脑细胞中,不应因如帕金森病中发生的那种有规律的神经元细胞丢失而特异性丧失。我们比较了6个人类大脑24个区域中GAD与代谢酶肌酸激酶(CK)、腺苷酸激酶、己糖激酶、β-葡萄糖醛酸酶以及苹果酸、乳酸、葡萄糖-6-磷酸和异柠檬酸脱氢酶的活性。在这些代谢酶中,只有CK的活性变化达5倍,接近GAD的变化程度。与GAD一样,CK活性在死后是稳定的,但其活性显然与临终前疾病的严重程度和持续时间呈负相关。CK可能是濒死期恶化的一个有用标志物。

相似文献

1
Regional activities of metabolic enzymes and glutamate decarboxylase in human brain.人脑中代谢酶和谷氨酸脱羧酶的区域活性
Ann Neurol. 1981 Oct;10(4):377-83. doi: 10.1002/ana.410100410.
2
Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.老年痴呆症中的神经递质酶异常。尸检脑组织中的胆碱乙酰转移酶和谷氨酸脱羧酶活性。
J Neurol Sci. 1977 Nov;34(2):247-65. doi: 10.1016/0022-510x(77)90073-9.
3
Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index.帕金森病中的脑谷氨酸脱羧酶,特别提及生前严重程度指数。
Brain. 1985 Jun;108 ( Pt 2):301-13. doi: 10.1093/brain/108.2.301.
4
The influence of systemic factors on acrylamide-induced changes in brain, nerve, and other tissues.
J Neurosci Res. 1984;11(4):395-404. doi: 10.1002/jnr.490110407.
5
Effects of some typical and atypical antidepressants on GAD activity in various brain regions.一些典型和非典型抗抑郁药对不同脑区中谷氨酸脱羧酶(GAD)活性的影响。
Encephale. 1982;8(1):89-94.
6
Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.对适合进行深部脑刺激的帕金森病患者进行丘脑底核谷氨酸脱羧酶基因转移。
Hum Gene Ther. 2001 Aug 10;12(12):1589-91.
7
[Protective effect of arginine in hyperoxia. Activity of cerebral glutaminase and glutamate decarboxylase].[精氨酸在高氧环境中的保护作用。脑谷氨酰胺酶和谷氨酸脱羧酶的活性]
Vopr Med Khim. 1978 Jan-Feb;24(1):42-6.
8
Cysteinesulfinate decarboxylase activity as an index of taurine-containing structures.半胱亚磺酸脱羧酶活性作为含牛磺酸结构的一个指标。
J Neurosci Res. 1980;5(6):555-62. doi: 10.1002/jnr.490050610.
9
Critical evaluation of postmortem changes in human autopsy cisternal fluid. Enzymes, electrolytes, acid-base balance, glucose and glycolysis, free amino acids and ammonia. Correlation to total brain ischemia.人体尸检脑池液死后变化的批判性评估。酶、电解质、酸碱平衡、葡萄糖与糖酵解、游离氨基酸和氨。与全脑缺血的相关性。
J Forensic Sci. 1993 May;38(3):603-16.
10
Damaged rat beta cells discharge glutamate decarboxylase in the extracellular medium.受损的大鼠β细胞在细胞外介质中释放谷氨酸脱羧酶。
Biochem Biophys Res Commun. 1996 Nov 12;228(2):293-7. doi: 10.1006/bbrc.1996.1655.

引用本文的文献

1
Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions.GABA 转氨酶失活剂的设计与机制。癫痫和成瘾的治疗方法。
Chem Rev. 2018 Apr 11;118(7):4037-4070. doi: 10.1021/acs.chemrev.8b00009. Epub 2018 Mar 23.
2
Mechanism of inactivation of γ-aminobutyric acid aminotransferase by (1S,3S)-3-amino-4-difluoromethylene-1-cyclopentanoic acid (CPP-115).(1S,3S)-3-氨基-4-二氟亚甲基-1-环戊烷羧酸(CPP-115)使γ-氨基丁酸转氨酶失活的机制
J Am Chem Soc. 2015 Feb 25;137(7):2628-40. doi: 10.1021/ja512299n. Epub 2015 Feb 10.
3
The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.
2011年E.B.赫什伯格奖授予在药用活性物质方面有重要发现者:(1S,3S)-3-氨基-4-二氟亚甲基-1-环戊烷羧酸(CPP-115),一种γ-氨基丁酸转氨酶失活剂及治疗药物成瘾和婴儿痉挛症的新疗法。
J Med Chem. 2012 Jan 26;55(2):567-75. doi: 10.1021/jm201650r. Epub 2012 Jan 10.
4
Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors.氟化构象受限的γ-氨基丁酸转氨酶抑制剂
J Med Chem. 2006 Dec 14;49(25):7404-12. doi: 10.1021/jm0608715.
5
Quantitative maps of GAbAergic and glutamatergic neuronal systems in the human brain.人类大脑中γ-氨基丁酸能和谷氨酸能神经元系统的定量图谱。
Hum Brain Mapp. 2000 Oct;11(2):93-103. doi: 10.1002/1097-0193(200010)11:2<93::AID-HBM30>3.0.CO;2-Y.